Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.

Kanu N, Cerone MA, Goh G, Zalmas LP, Bartkova J, Dietzen M, McGranahan N, Rogers R, Law EK, Gromova I, Kschischo M, Walton MI, Rossanese OW, Bartek J, Harris RS, Venkatesan S, Swanton C.

Genome Biol. 2016 Sep 15;17(1):185. doi: 10.1186/s13059-016-1042-9.

2.

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing.

Sims D, Mendes-Pereira AM, Frankum J, Burgess D, Cerone MA, Lombardelli C, Mitsopoulos C, Hakas J, Murugaesu N, Isacke CM, Fenwick K, Assiotis I, Kozarewa I, Zvelebil M, Ashworth A, Lord CJ.

Genome Biol. 2011 Oct 21;12(10):R104. doi: 10.1186/gb-2011-12-10-r104.

3.

Functional viability profiles of breast cancer.

Brough R, Frankum JR, Sims D, Mackay A, Mendes-Pereira AM, Bajrami I, Costa-Cabral S, Rafiq R, Ahmad AS, Cerone MA, Natrajan R, Sharpe R, Shiu KK, Wetterskog D, Dedes KJ, Lambros MB, Rawjee T, Linardopoulos S, Reis-Filho JS, Turner NC, Lord CJ, Ashworth A.

Cancer Discov. 2011 Aug;1(3):260-73. doi: 10.1158/2159-8290.CD-11-0107. Epub 2011 Aug 2.

4.

High-throughput RNAi screening reveals novel regulators of telomerase.

Cerone MA, Burgess DJ, Naceur-Lombardelli C, Lord CJ, Ashworth A.

Cancer Res. 2011 May 1;71(9):3328-40. doi: 10.1158/0008-5472.CAN-10-2734.

5.

Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer.

McCabe N, Cerone MA, Ohishi T, Seimiya H, Lord CJ, Ashworth A.

Oncogene. 2009 Mar 19;28(11):1465-70. doi: 10.1038/onc.2008.483. Epub 2009 Feb 2.

PMID:
19182824
6.

Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons.

Jain P, Cerone MA, Leblanc AC, Autexier C.

J Neurosci Res. 2007 Jan;85(1):83-9.

PMID:
17075923
7.

Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells.

Cerone MA, Londoño-Vallejo JA, Autexier C.

Mol Cancer Ther. 2006 Jul;5(7):1669-75.

8.

Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.

Cerone MA, Londoño-Vallejo JA, Autexier C.

Oncogene. 2006 Nov 30;25(56):7411-20. Epub 2006 Jun 12. Erratum in: Oncogene. 2007 Mar 22;26(13):1983.

PMID:
16767163
9.

A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation.

Marie-Egyptienne DT, Cerone MA, Londoño-Vallejo JA, Autexier C.

Nucleic Acids Res. 2005 Sep 28;33(17):5446-57. Print 2005.

10.

A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.

Cerone MA, Autexier C, Londoño-Vallejo JA, Bacchetti S.

Oncogene. 2005 Nov 24;24(53):7893-901.

PMID:
16116482
11.

Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.

Capponcelli S, Pedrini E, Cerone MA, Corti V, Fontanesi S, Alessio M, Bachi A, Soddu S, Ribatti D, Picci P, Helman LJ, Cantelli-Forti G, Sangiorgi L.

Hum Mutat. 2005 Aug;26(2):94-103.

PMID:
15977174
12.

Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.

Cerone MA, Ward RJ, Londoño-Vallejo JA, Autexier C.

Cell Cycle. 2005 Apr;4(4):585-9. Epub 2005 Apr 3.

PMID:
15753647
13.

Telomere maintenance by telomerase and by recombination can coexist in human cells.

Cerone MA, Londono-Vallejo JA, Bacchetti S.

Hum Mol Genet. 2001 Sep 1;10(18):1945-52.

PMID:
11555631
15.

p53 regulates myogenesis by triggering the differentiation activity of pRb.

Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, Cimino L, Piaggio G, Sacchi A, Soddu S.

J Cell Biol. 2000 Dec 11;151(6):1295-304.

16.

p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts.

Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S.

Cell Death Differ. 2000 May;7(5):506-8. No abstract available.

17.

In vitro low propensity to form nucleosomes of four telomeric sequences.

Cacchione S, Cerone MA, Savino M.

FEBS Lett. 1997 Jan 2;400(1):37-41.

18.

Supplemental Content

Loading ...
Support Center